Back to Search Start Over

Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis

Authors :
Acharya, S
Lim, L-L
Lau, ESH
Ozaki, R
Chung, H
Fu, AWC
Chan, W
Kong, APS
Ma, RCW
So, W-Y
Chow, E
Cheung, KKT
Yau, T
Chow, CC
Lau, V
Yue, R
Ng, S
Zee, B
Goggins, W
Oldenburg, B
Clarke, PM
Lau, M
Wong, R
Tsang, CC
Gregg, EW
Wu, H
Tong, PCY
Ko, GTC
Luk, AOY
Chan, JCN
Acharya, S
Lim, L-L
Lau, ESH
Ozaki, R
Chung, H
Fu, AWC
Chan, W
Kong, APS
Ma, RCW
So, W-Y
Chow, E
Cheung, KKT
Yau, T
Chow, CC
Lau, V
Yue, R
Ng, S
Zee, B
Goggins, W
Oldenburg, B
Clarke, PM
Lau, M
Wong, R
Tsang, CC
Gregg, EW
Wu, H
Tong, PCY
Ko, GTC
Luk, AOY
Chan, JCN
Publication Year :
2020

Abstract

BACKGROUND: Diabetes outcomes are influenced by host factors, settings, and care processes. We examined the association of data-driven integrated care assisted by information and communications technology (ICT) with clinical outcomes in type 2 diabetes in public and private healthcare settings. METHODS AND FINDINGS: The web-based Joint Asia Diabetes Evaluation (JADE) platform provides a protocol to guide data collection for issuing a personalized JADE report including risk categories (1-4, low-high), 5-year probabilities of cardiovascular-renal events, and trends and targets of 4 risk factors with tailored decision support. The JADE program is a prospective cohort study implemented in a naturalistic environment where patients underwent nurse-led structured evaluation (blood/urine/eye/feet) in public and private outpatient clinics and diabetes centers in Hong Kong. We retrospectively analyzed the data of 16,624 Han Chinese patients with type 2 diabetes who were enrolled in 2007-2015. In the public setting, the non-JADE group (n = 3,587) underwent structured evaluation for risk factors and complications only, while the JADE (n = 9,601) group received a JADE report with group empowerment by nurses. In a community-based, nurse-led, university-affiliated diabetes center (UDC), the JADE-Personalized (JADE-P) group (n = 3,436) received a JADE report, personalized empowerment, and annual telephone reminder for reevaluation and engagement. The primary composite outcome was time to the first occurrence of cardiovascular-renal diseases, all-site cancer, and/or death, based on hospitalization data censored on 30 June 2017. During 94,311 person-years of follow-up in 2007-2017, 7,779 primary events occurred. Compared with the JADE group (136.22 cases per 1,000 patient-years [95% CI 132.35-140.18]), the non-JADE group had higher (145.32 [95% CI 138.68-152.20]; P = 0.020) while the JADE-P group had lower event rates (70.94 [95% CI 67.12-74.91]; P < 0.001). The adjusted hazard ratio

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1315693477
Document Type :
Electronic Resource